Literature DB >> 15539749

Clozapine-induced hypersensitivity myocarditis.

Maurizio Pieroni1, Roberto Cavallaro, Cristina Chimenti, Enrico Smeraldi, Andrea Frustaci.   

Abstract

A rare, but frequently fatal, side effect of the antipsychotic drug clozapine is myocarditis. We report a case of hypersensitivity myocarditis secondary to clozapine administration that was diagnosed in vivo for the first time through endomyocardial biopsy and was successfully treated with corticosteroids. Histologic diagnosis was based on the evidence of eosinophilic infiltration of the endomyocardium and eosinophil degranulation. Endomyocardial biopsy was performed in order to establish or exclude a clear-cut relationship between cardiac dysfunction and clozapine, and was crucial to establish a correct diagnosis and appropriate treatment. Clozapine withdrawal and targeted 8-day, low-dose corticosteroid therapy resolved the symptoms and restored cardiac function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15539749     DOI: 10.1378/chest.126.5.1703

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Hypersensitivity myocarditis induced by beta-blockers: an unexpected cause of abrupt deterioration in hypertrophic cardiomyopathy.

Authors:  Andrea Frustaci; Romina Verardo; Patrizio Sale; Federico Toscano; Giuseppe Critelli; Matteo A Russo; Cristina Chimenti
Journal:  Intensive Care Med       Date:  2007-06-26       Impact factor: 17.440

Review 2.  Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

Authors:  Domenico De Berardis; Gabriella Rapini; Luigi Olivieri; Domenico Di Nicola; Carmine Tomasetti; Alessandro Valchera; Michele Fornaro; Fabio Di Fabio; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Ther Adv Drug Saf       Date:  2018-02-06

Review 3.  Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management.

Authors:  Kathlyn J Ronaldson
Journal:  CNS Drugs       Date:  2017-09       Impact factor: 5.749

Review 4.  Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003.

Authors:  Steven J Haas; Richard Hill; Henry Krum; Danny Liew; Andrew Tonkin; Lisa Demos; Karen Stephan; John McNeil
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 5.  When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.

Authors:  Peter Manu; Deepak Sarpal; Owen Muir; John M Kane; Christoph U Correll
Journal:  Schizophr Res       Date:  2011-11-22       Impact factor: 4.939

Review 6.  Systematic Review of Clozapine Cardiotoxicity.

Authors:  Martina Curto; Nicoletta Girardi; Luana Lionetto; Giuseppino M Ciavarella; Stefano Ferracuti; Ross J Baldessarini
Journal:  Curr Psychiatry Rep       Date:  2016-07       Impact factor: 5.285

7.  Clozapine-induced hypersensitivity myocarditis presenting as sudden cardiac death.

Authors:  Natraj Katta; Sudarshan Balla; Kul Aggarwal
Journal:  Autops Case Rep       Date:  2016-12-30

8.  Myocarditis-associated necrotizing coronary vasculitis: incidence, cause, and outcome.

Authors:  Andrea Frustaci; Maria Alfarano; Romina Verardo; Chiara Agrati; Rita Casetti; Fabio Miraldi; Nicola Galea; Claudio Letizia; Cristina Chimenti
Journal:  Eur Heart J       Date:  2021-04-21       Impact factor: 29.983

9.  Short-term use of "ECMELLA" in the context of fulminant eosinophilic myocarditis with cardiogenic shock.

Authors:  Mintje Bohné; Da-Un Chung; Eike Tigges; Hendrick van der Schalk; Daniela Waddell; Niklas Schenker; Stephan Willems; Karin Klingel; Dietmar Kivelitz; Edda Bahlmann
Journal:  BMC Cardiovasc Disord       Date:  2020-12-10       Impact factor: 2.298

10.  Iatrogenic myocarditis-biomarkers, cardiovascular MRI and the need for early diagnosis.

Authors:  Amrit S Lota; Brian P Halliday; Vassilios S Vassiliou
Journal:  Oxf Med Case Reports       Date:  2018-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.